Antibacterial prophylaxis for gram-positive and gram-negative infections in cranial surgery: A meta-analysis. (November 2017) - Abraham, Pranav
Highlights: Among cranial surgery patients, compared to 1 st generation cephalosporin: Lincosamides and glycopeptides offer better coverage against SSIs. Third generation cephalosporins offer better coverage against SSIs. Other combinations of prophylactic antibiotics offer better coverage against SSIs. Penicillin-family antibiotics alone offer better coverage against SSIs. Abstract: Background: Perioperative antibiotic prophylaxis against gram positive and gram negative infections is considered standard of care in the perioperative management of patients undergoing cranial surgery. The antibiotic regimen which best reduces the risk of surgical site infections (SSIs) remains controversial. Objectives: A systematic literature review and meta-analysis were conducted to examine the effect of various prophylactic antibiotics on infection incidence among patients undergoing cranial surgeries. Methods: A comprehensive search was conducted on Pubmed, EMBASE and Cochrane databases through October 2014 for studies that evaluated the efficacy of antibiotic prophylaxis among patients undergoing cranial surgeries. Pooled effect estimates using both fixed- and random-effect models were calculated. Results: Eight articles were included in the meta-analysis, with a combined total of 1655 cranial procedures. Among these, 74 cases of SSIs were reported after patients received a single antibiotic or a combination of 2 or more antibiotics (pooled incidence of SSIs = 6.00%; 95% CI = 4.80%, 7.50%; fixed-effects model; I 2 = 73.7%; P-heterogeneity < 0.01). Incidence of SSI was 1.00% (95% CI = 0.40%, 2.60%) for non-MRSA gram-positive bacterial infections; 2.70% (95% CI = 0.90%, 8.00%) for gram-negative bacterial infections; 6.00% (95% CI = 4.50%, 7.80%) for gram negative, and non-MRSA gram-positive bacterial infections; and 11.3% (95% CI = 7.20%, 17.4%) for gram negative and MRSA gram-positive bacterial infections. Subgroup analysis revealed an effect modification by drug class (P = 0.05) and infection type (P-interaction = 0.01). More specifically, lincosamides (2.70%; n = 1 group), glycopeptides (2.80%; n = 1), third generation cephalosporins (5.30%; n = 2), antibiotics combination (4.90%; n = 4), and penicillin-family antibiotics (5.90%, n = 1) offered better coverage against infections than first generation cephalosporins (22.0%; n = 2). A meta-regression analysis on study length was not significant (P = 0.13). Random-effect models were not materially different form fixed-effects. No evidence of publication bias was found. Conclusion: Lincosamides, glycopeptides, third generation cephalosporins, other combinations of prophylactic antibiotics, or penicillin-family antibiotics alone offer better coverage against SSIs than first generation cephalosporin among cranial surgery patients.